Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-04-04

Clinical Trial Update: CAPTURE Study (Polyglucosamine for Cardio & Atherosclerosis Prevention and Treatment Via Fat Uptake REduction) [NA]

View source ↗

Summary

This entry notes the CAPTURE clinical trial studying polyglucosamine for prevention and treatment of atherosclerotic disease, which is currently not yet recruit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Polyglucosamine (polyglucosamine)

Snippet

Sponsor: Certmedica International GmbH | Conditions: Atherosclerotic Disease | NA | Status: NOT_YET_RECRUITING